Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jaffe, E. S.
Right arrow Articles by Raffeld, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Jaffe, E. S.
Right arrow Articles by Raffeld, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 8:S17-S24, 1997
© 1997 European Society for Medical Oncology

Classification of T-cell and NK-cell neoplasms based on the REAL classification*

E. S. Jaffe, L. Krenacs and M. Raffeld

Hematopathology Section, Laboratory of Pathology, National Cancer Institute Bethesda, MD, USA

Correspondence to: Dr. Elaine S. Jaffe Building 10, Room 2N202 MSC-1500 10 Center Drive Bethesda, MD 20892-1500 USA

Mature or peripheral T-cell lymphomas are uncommon, accounting for only 10%–15% of all non-Hodgkin's lymphomas. The classification of these neoplasms has been controversial. In contrast to B-cell lymphomas, cytologic grade has not been very useful in predicting the clinical course. This finding may result from the generally aggressive clinical course associated with T-cell lymphomas. Prior studies have suggested that stage of disease may be more important than cytologic subtype.

Clinical presentation is very important in the classification of T-cell malignancies. For T-cell lymphomas, cytologic features alone are not sufficient to distinguish among disease entities. For example, adult T-cell leukemia/lymphoma (ATLL) often cannot be distinguished morphologically from HTLV-1-negative T-cell lymphomas. Most extranodal T-cell lymphomas appear to be derived from cytotoxic T cells, which express perforin, TIA-1, and granzyme B. Three broad groups of T-cell malignancies can be identified: (1) leukemic or systemic disease; (2) nodal disease; (3) extranodal disease. Anaplastic large-cell lym-phoma (ALCL) is probably the single most common subtype of T-cell lymphoma. Classical ALCL should be distinguished from primary cutaneous ALCL (CD30+ lymphoproliferative disease of the skin), which is a distinct disease entity.

cytotoxic T cells, T-cell lymphoma

* The US Government right to retain a non-exclusive, royalty-free licence in and to any copyright is acknowledged.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BloodHome page
J. R. Toro, D. J. Liewehr, N. Pabby, L. Sorbara, M. Raffeld, S. M. Steinberg, and E. S. Jaffe
Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma
Blood, May 1, 2003; 101(9): 3407 - 3412.
[Abstract] [Full Text] [PDF]

Home page
 Vet PatholHome page
C. Fournel-Fleury, F. Ponce, P. Felman, A. Blavier, C. Bonnefont, L. Chabanne, T. Marchal, J. L. Cadore, I. Goy-Thollot, D. Ledieu, et al.
Canine T-cell Lymphomas: A Morphological, Immunological, and Clinical Study of 46 New Cases
Vet. Pathol., January 1, 2002; 39(1): 92 - 109.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.